How Ph.D. was paid
$647,582 in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Other | Total |
|---|---|---|---|---|
| Werner Cautreels, Ph.D.Former Chief Executive Officer | $445,769 | $200,000 | $1,813 | $647,582 |
| Steven M. Fruchtman, M.D.Former President and Chief Executive Officer | $332,887 | — | $77,113 | $410,000 |
| Mark P. GuerinFormer Chief Financial Officer and Chief Operating Officer | $520,850 | — | $41,898 | $562,747 |
| Victor Moyo, M.D.Chief Medical Officer – Oncology | $453,107 | — | $25,329 | $478,436 |
What changed and why
- 647,582 was Werner Cautreels’s 2024 total compensation, including 200,000 in restricted stock units.
- 410,000 was Steven Fruchtman’s 2024 total compensation, including 77,113 in other compensation.
- 562,747 was Mark Guerin’s 2024 total compensation, including 41,898 in other compensation.
- 478,436 was Victor Moyo’s 2024 total compensation, including 25,329 in other compensation.
- 52,946 of Fruchtman’s other compensation represented paid time off.
- Cautreels received 8,000 inducement RSUs, vesting over four years subject to continued service.
Other Traws Pharma proxy statements
- 2026 proxy statement
Iain Dukes, D. Phil. paid $1.4M.
Filed May 29, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.